We evaluated the bioavailability of two types of calcium from milk in two experiments. One was a micellar calcium phosphate phosphopeptide (MCP-PP) complex in which the chemical form was similar to the original form of milk, and the other was a commercial whey calcium in which the chemical form was different from that of milk. In experiment 1, the calcium absorption, bone mineral density, and bone strength were examined when growing female rats were fed either MCP-PP complex or whey calcium as the sole source of calcium for 46d. In experiment 2, the calcium solubility in the small intestine was measured when female rats were meal-fed either MCP-PP complex or whey calcium. The apparent calcium absorption rate in both groups decreased time-dependently during the experimental period, but the time-dependent change in the apparent calcium absorption rate was statistically different. It decreased more slowly in rats fed the MCP-PP diet than in rats fed the whey calcium diet. The bone mineral density of the femur in rats fed the MCP-PP diet was significantly higher than that of the rats fed the whey calcium diet. The bone strength (breaking force and energy) of the femur in rats fed the MCP-PP diet was higher than in the rats fed the whey calcium diet. The amount of soluble calcium in the small intestinal contents in rats at 2.5h after ingestion of the MCP-PP diet was approximately three times higher than that found in rats fed the whey calcium diet. These results indicate that the calcium bioavailability of MCP-PP complex is higher than that of whey calcium, and this difference is due in part to the solubility in the intestine.
Summary
We evaluated the bioavailability of two types of calcium from milk in two experiments. One was a micellar calcium phosphate phosphopeptide (MCP-PP) complex in which the chemical form was similar to the original form of milk, and the other was a commercial whey calcium in which the chemical form was different from that of milk. In experiment 1, the calcium absorption, bone mineral density, and bone strength were examined when growing female rats were fed either MCP-PP complex or whey calcium as the sole source of calcium for 46d. In experiment 2, the calcium solubility in the small intestine was measured when female rats were meal-fed either MCP-PP complex or whey calcium. The apparent calcium absorption rate in both groups decreased time-dependently during the experimental period, but the time-dependent change in the apparent calcium absorption rate was statistically different. It decreased more slowly in rats fed the MCP-PP diet than in rats fed the whey calcium diet. The bone mineral density of the femur in rats fed the MCP-PP diet was significantly higher than that of the rats fed the whey calcium diet. The bone strength (breaking force and energy) of the femur in rats fed the MCP-PP diet was higher than in the rats fed the whey calcium diet. The amount of soluble calcium in the small intestinal contents in rats at 2.5h after ingestion of the MCP-PP diet was approximately three times higher than that found in rats fed the whey calcium diet. These results indicate that the calcium bioavailability of MCP-PP complex is higher than that of whey calcium, and this difference is due in part to the solubility in the intestine. Key Words milk, calcium, Phosphopeptide, bioavailability, rats Milk is an excellent source of calcium, considering the absorption of calcium and its bioavailability (1) (2) (3) . Therefore, large-scale preparation methods have been developed to recover calcium from acid whey for calcium supplementation (4) . The high bioavailability of calcium supplements prepared from whey and rennet casein has been reported by several researchers (5) (6) (7) (8) .
About two-thirds of the calcium and half of the inorganic phosphate of milk are present in casein micelles. Calcium phosphate in casein micelles is called micellar calcium phosphate (MCP) or colloidal calcium phosphate (9, 10) . MCP binds to phosphate groups of casein and cross-links casein molecules through their phosphate groups (11, 12) . Calcium and inorganic phosphate in MCP are in quasi-equilibrium with those in soluble phase. Wong and LaCroix (3) compared the calcium bioavailability in nonfat dry milk (which contains the whole calcium in milk), in yogurt (ionic calcium), and in rennet casein (MCP and calcium caseinate) with that in calcium carbonate in rats. The results indicated that rennet casein was the best source of calcium concerning bioavailability. It is noteworthy to mention that calcium bioavailability from dairy products is superior. However, to estimate the bioavailability of calcium itself from milk, an isolated calcium is needed whose chemical form is similar to that in milk because dairy products contain several components in calcium bioavailability, such as lactose (13) (14) (15) and phosphopeptides formed by proteolytic digestion of milk casein (16) (17) (18) (19) .
As mentioned above, calcium has been separated from whey and rennet casein, but the chemical form of calcium from whey and rennet casein is considered to be different from that of the original chemical form of calcium from MCP in milk. The chemical form of calcium from whey and rennet casein is a crystal such as hydroxyapatite; the original form from MCP of milk is amorphous calcium phosphate (6, 20, 21) . When calcium is separated from whey and rennet casein, the precipitate of amorphous calcium is formed and transformed into hydroxyapatite crystal because the amorphous calcium is unstable. In milk, the transformation of MCP into hydroxyapatite is prevented by casein. The calcium in excess of its solubility in milk is present as MCP binding to phosphate groups of casein (11, 12) . Recently, we separated MCP from rennet casein as the complex with phosphopeptide (20) . The phosphopeptide and the phosphate groups of casein were considered to stabilize amorphous calcium and prevent the formation of hydroxyapatite. We confirmed that the form of calcium phosphate in the MCP-phosphopeptide (MCP-PP) complex was similar to that of casein micelles by X-ray diffraction and HPLC analysis. That is, the form of the MCP-PP complex was considered to be amorphous calcium phosphate as well as that of casein micelles in milk.
The purpose of this study is to evaluate the calcium bioavailability from the MCP-PP complex in comparison with the hydroxyapatite calcium of whey calcium by examining calcium absorption and bone mineral density in growing female rats. We also studied calcium solubility in the small intestine. 5g of AIN-76 diet (25, 26) for 1.5h twice a day (0800-0930h and 1700-1830h) and given free access to deionized water for a 7-d training period. After training, all rats were separated into two experimental groups of four rats each. The experimental groups and diets were the same as that in experiment 1 (Table 1) . Rats were fed 5g of each experimental diet for 1.5h (0800-0930h). Rats were sacrificed 1h after withdrawal of the diet. All experimental rats were anesthetized with diethyl ether. The entire small intestinal contents, from proximal duodenum to distal ileum, were thoroughly flushed out with ice-cold saline (9g/L) and mace up to a known volume with the same solution. The intestinal contents were then centrifuged to obtain the supernatant fraction. The soluble calcium was defined as calcium in the supernatant fraction. The soluble calcium contents in the supernatant fraction were determined using the Calcium Test-Wako (Wako Pure Chemical).
Statistical analysis
The data reported in the tables are the mean values with SD, and the figures are expressed as means with 95% confidence intervals. Statistical analysis was done by one-way ANOVA. Apparent calcium absorption was analyzed by repeated measurement ANOVA to evaluate the time-dependent change between the two groups. All calculations were performed using Super ANOVA software (Abacus Concepts, CA, USA). Significance was assigned at p<0.05.
RESULTS

Experiment 1
Body weight and food intake. The final body weight, weight gain, food intake, and food efficiency were not significantly different between the experimental groups (Table 3) .
Calcium absorption rate. The apparent calcium absorption rate in both groups decreased with time ( Fig. 1) . However, the time-dependent changes in the apparent calcium absorption rate were significantly different between the experimental groups (p<0.05). The change in rats fed the MCP-PP diet decreased more slowly than in rats fed the whey calcium diet. Bone mineral density and calcium contents. The BMD and BMC of the femur in rats fed the MCP-PP diet were significantly higher than in rats fed the whey calcium diet (p<0.01) ( Table 4 ). The calcium contents of the femur in rats fed the MCP-PP diet were significantly higher than in rats fed the whey calcium diet (p<0.05) ( Table 4 ). The calcium content of the femur was found to be related to the BMC, with the correlation coefficient at 0.97 (p<0.01). The BMC of segments of the excised femur were calculated by dividing the whole femur into five segments of equal length. Each segmental BMC value from rats fed the MCP-PP diet was significantly higher than that from rats fed the whey calcium diet (Fig . 2) . The BMD of the excised lumbar vertebra (L4) tended to be higher than that in rats fed the whey calcium diet (p=0.096). A significant difference in the BMC was not observed among the experimental groups (Table 4) . Breaking strength of femur. The breaking force of the excised femur in rats fed the MCP-PP diet tended to be higher than that in rats fed the whey calcium diet (p=0.095) ( Table 4 ). The breaking energy of the excised femur in rats fed the MCP-PP diet was significantly higher than that in rats fed the whey calcium diet (p<0.05) ( Table 4) . Serum analysis. The serum calcium level, alkaline phosphatase activity , tartrate-resistant acid phosphatase activity, blood urea nitrogen level, and creatinine level were not significantly different between the experimental groups (Table 5) .
Experiment 2
The amount of soluble calcium in the small intestinal contents . The amount of soluble calcium in the small intestinal contents in rats fed the MCP-PP diet was significantly higher than that in rats fed the whey calcium diet (p<0 .01) (Fig. 3) . The amount of soluble calcium in the small intestinal contents in rats fed the MCP-PP diet was approximately three times higher than that in rats fed the whey calcium diet. Fig. 3 . Soluble calcium in the small intestinal contents of rats at 2.5h after ingestion of 5g of a whey calcium diet (Whey Ca) or 5g of a micellar calcium phosphate-phosphopeptide complex diet (MCP-PP) in experiment 2. Values are mean 95% confidence intervals, n=4. ** indicates significant differences compared with the Whey Ca group (p<0.01).
DISCUSSION
The apparent calcium absorption rate in both groups decreased time dependently during the experimental period. This decrease may correspond to a decrease in the organism's requirement with age. Armbrecht et al (27) indicated that the active transport component of the absorption mechanism declined with age. The saturable process developed rapidly beginning at 18d of age and peaked at 20 to 40d (28) . It then declined rapidly and little active transport was present beyond 3mo (29) . In our study, calcium absorption studies were performed at 7, 9, and 12-wk-old. When the apparent calcium absorption rate was analyzed by repeated measurement ANOVA, the time-dependent changes in the apparent calcium absorption rate were significantly different between the experimental groups. The change in rats fed the MCP-PP diet decreased more slowly than that in rats fed the whey calcium diet. These results suggest that the difference in calcium absorption rate between the MCP-PP complex and whey calcium is distinct at the latter period of this experiment when active transport might be declining and passive transport might exceed active transport. The difference in calcium absorption rate between MCP-PP complex and whey calcium might be clearer in aged rats. As for the serum calcium level at the end of the experiment, no significant differences were found between the experimental groups because the serum calcium level is presumably regulated through the homeostatic mechanism (30) .
The BMD, BMC, and calcium content of the femur in rats fed the MCP-PP diet were significantly higher than those in rats fed the whey calcium diet. These results suggest that calcium deposition in the bone of rats fed the MCP-PP diet is higher than that in the bone of rats fed whey calcium because calcium absorption of MCP-PP complex is superior to that of whey calcium at the latter period. Moreover, we calculated the BMC of segments of the excised femur by dividing the whole femur into five segments of equal length. Every segmental BMC value from the rats fed MCP-PP diet was significantly higher than that from rats fed the whey calcium diet. The femoral metaphysis (both ends of the femur) contains cortical bone and trabecular bone, and the femoral diaphysis (center of the femur) mainly contains cortical bone. The higher BMD of every femoral segment of rats fed the MCP-PP diet suggests that calcium from MCP-PP was highly deposited in the trabecular and cortical bones in comparison with the calcium from whey calcium. Moreover, we measured bone strength (the breaking force and breaking energy) using a three-point bending method to investigate the dynamic strength of the femur. The breaking energy of the excised femur in rats fed the MCP-PP diet was significantly higher than that in rats fed the whey calcium diet, and the breaking force of the excised femur in rats fed the MCP-PP diet tended to be higher than that in rats fed the whey calcium diet. It is considered that bone strength mainly reflects bone mineral, so the higher bone strength of rats fed the MCP-PP diet is considered to be caused by a higher content of bone mineral.
Moreover, we studied the effect of the MCP-PP complex on renal function. In all rats of both groups, unusual renal features such as calcification were not observed with the naked eye. The serum blood urea nitrogen level and creatinine level, the markers of renal function, were not significantly different between the experimental groups. Therefore, the MCP-PP complex was considered to have no adverse effect on the kidneys when the calcium and phosphorus concentrations in diets were 0.5 and 0.4%, respectively.
As mentioned above, whey calcium is considered to be a good calcium source because of the absorption of calcium and its bioavailability (5, 7, 8) . However, our results indicate that calcium in the MCP-PP complex, in which the form of calcium phosphate is similar to that found in milk, is a higher bioavailable source than that in whey calcium. We used commercial CPP as the phosphopeptide to prepare the MCP-PP complex. It is considered that CPP enhances calcium absorption by increasing calcium solubility (16) (17) (18) (19) , although Brommage et al reported that a positive effect of CPP on calcium balance in animals was not shown (31) . To evaluate the effect of the MCP-PP complex on calcium bioavailability, CPP was also added to the whey calcium diet. Therefore the positive effects on calcium bioavailability shown in this study are considered not to be the effects of CPP, but to be those of the MCP-PP complex chemical form itself.
We measured the amount of soluble calcium in the small intestinal contents of rats fed the MCP-PP diet to examine the possible mechanism. Lee et al (16, 17) indicated that the ingestion of casein or CPP resulted in a higher soluble calcium concentration in the small, intestine. In their experiment of CPP supplementation (17) , they indicated that the amount of soluble calcium in the small intestinal contents in rats fed the CPP diet was 1.2mg, and the amounts in rats fed the control diet was 0.5mg when calcium intake was approximately 25mg. In our study, rats were fed 5g of each experimental diet, which contained 25mg of calcium, for 1.5h, and the small intestinal contents were collected 1h after diet withdrawal. The amount of soluble calcium in the small intestinal contents of rats fed the whey calcium diet containing CPP was 1.2mg. This value was similar to that reported by Lee et al (17) . The amount of soluble calcium in the small intestinal contents of rats fed the MCP-PP diet was approximately three times higher than that in rats fed the whey calcium diet. It is considered that the calcium solubility in the intestine is one factor that affected calcium absorption (16, 17) . We support the view that an elevated concentration of soluble calcium during food ingestion enhances calcium absorption because we demonstrated higher calcium absorption and higher calcium solubility in the intestine. That is, our results suggest that calcium solubility in the small intestine would be one possible mechanism. We could speculate that MCP might partially keep the colloidal form in the stomach and might have diffi4culty forming an insoluble salt.
In conclusion, these results indicate that calcium bioavailability in the MCP-PP complex is excellent in comparison with that in whey calcium. Moreover, we suggest that its calcium solubility in the small intestine would bd one possible mechanism. Further studies of the absorption mechanism of calcium in the MCP-PP complex are needed to confirm our conclusion.
